This HTML5 document contains 60 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n15http://linked.opendata.cz/resource/drugbank/drug/DB06150/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n18http://linked.opendata.cz/resource/mesh/concept/
n16http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB06150/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB06150/identifier/wikipedia/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB06150/identifier/pharmgkb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n17http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/ontology/sukl/drug/
n10http://linked.opendata.cz/resource/atc/
n6http://linked.opendata.cz/resource/drugbank/drug/DB06150/identifier/kegg-drug/

Statements

Subject Item
n2:DB06150
rdf:type
n3:Drug
n3:description
Sulfadimethoxine is a sulfonamide antibiotic. Sulfadimethoxine is used to treat many infections including treatment of respiratory, urinary tract, enteric, and soft tissue infections. It is most frequently used in veterinary medicine, although it is approved in some countries for use in humans. Sulfadimethoxine inhibits bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. Sulfadimethoxine is approved in Russia for use in humans, including children, and has been successfully used there for more than 35 years. It is widely available in Russia as an over-the-counter drug manufactured by a number of Russian pharmaceutical companies.
n3:group
approved
n3:indication
For use in the treatment of infections.
owl:sameAs
n14:DB06150 n16:DB06150
dcterms:title
Sulfadimethoxine
adms:identifier
n6:D01142 n7:PA165958357 n8:32161 n11:Sulfadimethoxine n15:DB06150
n3:synonym
6-Sulfanilamido-2,4-dimethoxypyrimidine Sulfadimetoxina Sulphadimethoxine Sulfadimethoxine Abcid (tn) N(1)-(2,6-Dimethoxy-4-pyrimidinyl)sulfanilamide 2,6-Dimethoxy-4-(P-aminobenzenesulfonamido)pyrimidine 4-amino-N-(2,6-Dimethoxy-4-pyrimidinyl)benzenesulfonamide Sulfadimethoxinum Agribon (tn) 2,4-dimethoxy-6-sulfanilamido-1,3-diazine Sulfadimethoxydiazine 2,6-Dimethoxy-4-sulfanilamidopyrimidine
n3:salt
n17:hasConcept
n18:M0020742
n3:IUPAC-Name
n4:271B491F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4925-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4924-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4921-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4922-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4923-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B491D-363D-11E5-9242-09173F13E4C5 n4:271B4935-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B491B-363D-11E5-9242-09173F13E4C5 n4:271B491E-363D-11E5-9242-09173F13E4C5 n4:271B4937-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B491C-363D-11E5-9242-09173F13E4C5
n9:hasATCCode
n10:J01ED01
n3:H-Bond-Acceptor-Count
n4:271B492B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B492C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4926-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4927-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4929-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4928-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B492A-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
122-11-2
n3:category
n3:Bioavailability
n4:271B4931-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4933-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4934-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4936-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4930-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B492F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4932-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4920-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B492D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B492E-363D-11E5-9242-09173F13E4C5